blindness from semaglutide Ozempic Sudden TGA issues warning over GLP-1-based

For the first 12 months of availability, the mean monthly growth of GLP-1 RA exceeded 85% and reached 200% for certain GLP-1 RA medications [5]

This issue is particularly relevant in cases of co-supplementation or the simultaneous use of pharmacological treatment, which often obscures the isolated effect of the supplement under investigation 53

This hormone plays a key role in regulating appetite, insulin response, and digestion

(2016) A phase I new approaches to neuroblastoma therapy study of buthionine sulfoximine and melphalan with autologous stem cells for recurrent/refractory high-risk neuroblastoma, Pediatr